nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—CYP2D6—Fingolimod—multiple sclerosis	0.0613	0.127	CbGbCtD
Trimipramine—ABCB1—Methylprednisolone—multiple sclerosis	0.0419	0.0868	CbGbCtD
Trimipramine—CYP3A4—Fingolimod—multiple sclerosis	0.039	0.0807	CbGbCtD
Trimipramine—HTR1D—trigeminal nucleus—multiple sclerosis	0.0341	0.171	CbGeAlD
Trimipramine—CYP2C19—Prednisone—multiple sclerosis	0.0315	0.0652	CbGbCtD
Trimipramine—HTR3A—area postrema—multiple sclerosis	0.031	0.155	CbGeAlD
Trimipramine—ABCB1—Mitoxantrone—multiple sclerosis	0.0306	0.0633	CbGbCtD
Trimipramine—ABCB1—Betamethasone—multiple sclerosis	0.0273	0.0564	CbGbCtD
Trimipramine—ABCB1—Prednisolone—multiple sclerosis	0.0269	0.0557	CbGbCtD
Trimipramine—ABCB1—Prednisone—multiple sclerosis	0.0254	0.0526	CbGbCtD
Trimipramine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0251	0.052	CbGbCtD
Trimipramine—HTR1D—meninx—multiple sclerosis	0.0227	0.113	CbGeAlD
Trimipramine—CYP2C19—Dexamethasone—multiple sclerosis	0.0197	0.0407	CbGbCtD
Trimipramine—CYP3A4—Triamcinolone—multiple sclerosis	0.019	0.0394	CbGbCtD
Trimipramine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0183	0.0379	CbGbCtD
Trimipramine—HTR2A—trigeminal nucleus—multiple sclerosis	0.017	0.0847	CbGeAlD
Trimipramine—CYP2C9—Dexamethasone—multiple sclerosis	0.0163	0.0338	CbGbCtD
Trimipramine—CYP3A4—Betamethasone—multiple sclerosis	0.0163	0.0338	CbGbCtD
Trimipramine—CYP3A4—Prednisolone—multiple sclerosis	0.0161	0.0334	CbGbCtD
Trimipramine—ABCB1—Dexamethasone—multiple sclerosis	0.0159	0.0328	CbGbCtD
Trimipramine—CYP3A4—Prednisone—multiple sclerosis	0.0152	0.0315	CbGbCtD
Trimipramine—CYP2D6—Dexamethasone—multiple sclerosis	0.0149	0.0309	CbGbCtD
Trimipramine—ABCB1—Methotrexate—multiple sclerosis	0.0127	0.0264	CbGbCtD
Trimipramine—CYP3A4—Dexamethasone—multiple sclerosis	0.0095	0.0197	CbGbCtD
Trimipramine—HTR1D—trigeminal nerve—multiple sclerosis	0.00897	0.0448	CbGeAlD
Trimipramine—HTR2A—trigeminal nerve—multiple sclerosis	0.00445	0.0222	CbGeAlD
Trimipramine—HTR3A—nerve—multiple sclerosis	0.00403	0.0201	CbGeAlD
Trimipramine—SLC6A3—nerve—multiple sclerosis	0.00335	0.0168	CbGeAlD
Trimipramine—HTR2A—pons—multiple sclerosis	0.00314	0.0157	CbGeAlD
Trimipramine—SLC6A2—nerve—multiple sclerosis	0.00271	0.0135	CbGeAlD
Trimipramine—DRD2—nerve—multiple sclerosis	0.00247	0.0123	CbGeAlD
Trimipramine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00245	0.0123	CbGeAlD
Trimipramine—HTR2A—pineal body—multiple sclerosis	0.00224	0.0112	CbGeAlD
Trimipramine—HTR2A—peripheral nervous system—multiple sclerosis	0.00209	0.0104	CbGeAlD
Trimipramine—HTR3A—brainstem—multiple sclerosis	0.00173	0.00864	CbGeAlD
Trimipramine—Benazepril—SLC15A2—multiple sclerosis	0.00167	0.464	CrCbGaD
Trimipramine—HTR2A—nerve—multiple sclerosis	0.00163	0.00812	CbGeAlD
Trimipramine—SLC6A3—brainstem—multiple sclerosis	0.00144	0.00719	CbGeAlD
Trimipramine—HTR1D—brainstem—multiple sclerosis	0.00141	0.00702	CbGeAlD
Trimipramine—HTR2C—brainstem—multiple sclerosis	0.00139	0.00695	CbGeAlD
Trimipramine—SLC6A4—brainstem—multiple sclerosis	0.00132	0.00659	CbGeAlD
Trimipramine—HTR1A—brainstem—multiple sclerosis	0.00117	0.00585	CbGeAlD
Trimipramine—SLC6A2—brainstem—multiple sclerosis	0.00116	0.0058	CbGeAlD
Trimipramine—ADRA1A—brainstem—multiple sclerosis	0.00108	0.00539	CbGeAlD
Trimipramine—DRD2—brainstem—multiple sclerosis	0.00106	0.00529	CbGeAlD
Trimipramine—DRD2—retina—multiple sclerosis	0.00102	0.0051	CbGeAlD
Trimipramine—ADRA1B—nervous system—multiple sclerosis	0.00101	0.00503	CbGeAlD
Trimipramine—HTR2C—medulla oblongata—multiple sclerosis	0.000971	0.00485	CbGeAlD
Trimipramine—ADRA1B—central nervous system—multiple sclerosis	0.00097	0.00484	CbGeAlD
Trimipramine—SLC6A3—midbrain—multiple sclerosis	0.000918	0.00458	CbGeAlD
Trimipramine—HTR3A—nervous system—multiple sclerosis	0.000907	0.00453	CbGeAlD
Trimipramine—HTR1D—midbrain—multiple sclerosis	0.000896	0.00447	CbGeAlD
Trimipramine—SLC6A3—spinal cord—multiple sclerosis	0.000896	0.00447	CbGeAlD
Trimipramine—HTR2C—midbrain—multiple sclerosis	0.000887	0.00443	CbGeAlD
Trimipramine—HTR3A—central nervous system—multiple sclerosis	0.000873	0.00436	CbGeAlD
Trimipramine—HTR2C—spinal cord—multiple sclerosis	0.000866	0.00432	CbGeAlD
Trimipramine—SLC6A4—midbrain—multiple sclerosis	0.000841	0.0042	CbGeAlD
Trimipramine—SLC6A4—spinal cord—multiple sclerosis	0.000821	0.0041	CbGeAlD
Trimipramine—SLC6A2—medulla oblongata—multiple sclerosis	0.00081	0.00405	CbGeAlD
Trimipramine—ADRA1B—brain—multiple sclerosis	0.00077	0.00385	CbGeAlD
Trimipramine—SLC6A3—nervous system—multiple sclerosis	0.000755	0.00377	CbGeAlD
Trimipramine—HTR1A—midbrain—multiple sclerosis	0.000747	0.00373	CbGeAlD
Trimipramine—HTR1D—nervous system—multiple sclerosis	0.000737	0.00368	CbGeAlD
Trimipramine—HTR2C—nervous system—multiple sclerosis	0.000729	0.00364	CbGeAlD
Trimipramine—HTR1A—spinal cord—multiple sclerosis	0.000729	0.00364	CbGeAlD
Trimipramine—SLC6A3—central nervous system—multiple sclerosis	0.000726	0.00363	CbGeAlD
Trimipramine—SLC6A3—cerebellum—multiple sclerosis	0.00071	0.00355	CbGeAlD
Trimipramine—HTR1D—central nervous system—multiple sclerosis	0.000709	0.00354	CbGeAlD
Trimipramine—HTR2C—central nervous system—multiple sclerosis	0.000702	0.00351	CbGeAlD
Trimipramine—HTR2A—brainstem—multiple sclerosis	0.000698	0.00349	CbGeAlD
Trimipramine—HTR3A—brain—multiple sclerosis	0.000693	0.00346	CbGeAlD
Trimipramine—SLC6A4—nervous system—multiple sclerosis	0.000691	0.00345	CbGeAlD
Trimipramine—DRD2—midbrain—multiple sclerosis	0.000675	0.00337	CbGeAlD
Trimipramine—HTR2A—retina—multiple sclerosis	0.000674	0.00336	CbGeAlD
Trimipramine—SLC6A4—central nervous system—multiple sclerosis	0.000666	0.00332	CbGeAlD
Trimipramine—Ethopropazine—BCHE—multiple sclerosis	0.000662	0.184	CrCbGaD
Trimipramine—CYP2D6—brainstem—multiple sclerosis	0.000636	0.00318	CbGeAlD
Trimipramine—HTR1A—nervous system—multiple sclerosis	0.000614	0.00307	CbGeAlD
Trimipramine—SLC6A2—nervous system—multiple sclerosis	0.000609	0.00304	CbGeAlD
Trimipramine—HTR1A—central nervous system—multiple sclerosis	0.000591	0.00295	CbGeAlD
Trimipramine—SLC6A2—central nervous system—multiple sclerosis	0.000586	0.00293	CbGeAlD
Trimipramine—HTR1A—cerebellum—multiple sclerosis	0.000578	0.00289	CbGeAlD
Trimipramine—SLC6A3—brain—multiple sclerosis	0.000577	0.00288	CbGeAlD
Trimipramine—ADRA2A—medulla oblongata—multiple sclerosis	0.000573	0.00286	CbGeAlD
Trimipramine—ADRA1A—nervous system—multiple sclerosis	0.000566	0.00283	CbGeAlD
Trimipramine—HTR1D—brain—multiple sclerosis	0.000563	0.00281	CbGeAlD
Trimipramine—HTR2C—brain—multiple sclerosis	0.000558	0.00278	CbGeAlD
Trimipramine—DRD2—nervous system—multiple sclerosis	0.000555	0.00277	CbGeAlD
Trimipramine—ADRA1A—central nervous system—multiple sclerosis	0.000545	0.00272	CbGeAlD
Trimipramine—DRD2—central nervous system—multiple sclerosis	0.000534	0.00267	CbGeAlD
Trimipramine—ADRA1A—cerebellum—multiple sclerosis	0.000533	0.00266	CbGeAlD
Trimipramine—SLC6A4—brain—multiple sclerosis	0.000529	0.00264	CbGeAlD
Trimipramine—ADRA2A—midbrain—multiple sclerosis	0.000523	0.00261	CbGeAlD
Trimipramine—DRD2—cerebellum—multiple sclerosis	0.000522	0.00261	CbGeAlD
Trimipramine—ADRA2A—spinal cord—multiple sclerosis	0.000511	0.00255	CbGeAlD
Trimipramine—HTR2A—medulla oblongata—multiple sclerosis	0.000487	0.00243	CbGeAlD
Trimipramine—HTR1A—brain—multiple sclerosis	0.000469	0.00234	CbGeAlD
Trimipramine—SLC6A2—brain—multiple sclerosis	0.000465	0.00232	CbGeAlD
Trimipramine—Arrhythmia—Prednisolone—multiple sclerosis	0.000455	0.00232	CcSEcCtD
Trimipramine—Discomfort—Mitoxantrone—multiple sclerosis	0.000455	0.00232	CcSEcCtD
Trimipramine—Feeling abnormal—Azathioprine—multiple sclerosis	0.00045	0.0023	CcSEcCtD
Trimipramine—HTR2A—midbrain—multiple sclerosis	0.000445	0.00222	CbGeAlD
Trimipramine—Confusional state—Mitoxantrone—multiple sclerosis	0.000445	0.00227	CcSEcCtD
Trimipramine—Dizziness—Cladribine—multiple sclerosis	0.000444	0.00227	CcSEcCtD
Trimipramine—ABCB1—retina—multiple sclerosis	0.000442	0.00221	CbGeAlD
Trimipramine—Oedema—Mitoxantrone—multiple sclerosis	0.000441	0.00225	CcSEcCtD
Trimipramine—HRH1—nervous system—multiple sclerosis	0.000438	0.00219	CbGeAlD
Trimipramine—HTR2A—spinal cord—multiple sclerosis	0.000434	0.00217	CbGeAlD
Trimipramine—ADRA1A—brain—multiple sclerosis	0.000433	0.00216	CbGeAlD
Trimipramine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000432	0.00221	CcSEcCtD
Trimipramine—Abdominal pain—Azathioprine—multiple sclerosis	0.000432	0.0022	CcSEcCtD
Trimipramine—Body temperature increased—Azathioprine—multiple sclerosis	0.000432	0.0022	CcSEcCtD
Trimipramine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000431	0.0022	CcSEcCtD
Trimipramine—ADRA2A—nervous system—multiple sclerosis	0.00043	0.00215	CbGeAlD
Trimipramine—Vomiting—Cladribine—multiple sclerosis	0.000427	0.00218	CcSEcCtD
Trimipramine—Erectile dysfunction—Prednisone—multiple sclerosis	0.000426	0.00217	CcSEcCtD
Trimipramine—DRD2—brain—multiple sclerosis	0.000424	0.00212	CbGeAlD
Trimipramine—Rash—Cladribine—multiple sclerosis	0.000423	0.00216	CcSEcCtD
Trimipramine—Hallucination—Dexamethasone—multiple sclerosis	0.000423	0.00216	CcSEcCtD
Trimipramine—Hallucination—Betamethasone—multiple sclerosis	0.000423	0.00216	CcSEcCtD
Trimipramine—Dermatitis—Cladribine—multiple sclerosis	0.000423	0.00216	CcSEcCtD
Trimipramine—HRH1—central nervous system—multiple sclerosis	0.000422	0.00211	CbGeAlD
Trimipramine—Weight increased—Prednisone—multiple sclerosis	0.000421	0.00215	CcSEcCtD
Trimipramine—Anorexia—Mitoxantrone—multiple sclerosis	0.000421	0.00215	CcSEcCtD
Trimipramine—Ataxia—Methotrexate—multiple sclerosis	0.000421	0.00215	CcSEcCtD
Trimipramine—Headache—Cladribine—multiple sclerosis	0.000421	0.00215	CcSEcCtD
Trimipramine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000419	0.00214	CcSEcCtD
Trimipramine—Vision blurred—Prednisolone—multiple sclerosis	0.000418	0.00213	CcSEcCtD
Trimipramine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000418	0.00213	CcSEcCtD
Trimipramine—ADRA2A—central nervous system—multiple sclerosis	0.000414	0.00207	CbGeAlD
Trimipramine—Hypotension—Mitoxantrone—multiple sclerosis	0.000412	0.0021	CcSEcCtD
Trimipramine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000412	0.0021	CcSEcCtD
Trimipramine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000407	0.00208	CcSEcCtD
Trimipramine—ADRA2A—cerebellum—multiple sclerosis	0.000405	0.00202	CbGeAlD
Trimipramine—Myocardial infarction—Prednisone—multiple sclerosis	0.000404	0.00206	CcSEcCtD
Trimipramine—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000404	0.00206	CcSEcCtD
Trimipramine—Malaise—Prednisolone—multiple sclerosis	0.0004	0.00204	CcSEcCtD
Trimipramine—Dysgeusia—Triamcinolone—multiple sclerosis	0.000399	0.00204	CcSEcCtD
Trimipramine—Nausea—Cladribine—multiple sclerosis	0.000399	0.00204	CcSEcCtD
Trimipramine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000396	0.00202	CcSEcCtD
Trimipramine—Somnolence—Mitoxantrone—multiple sclerosis	0.000392	0.002	CcSEcCtD
Trimipramine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000388	0.00198	CcSEcCtD
Trimipramine—Convulsion—Prednisolone—multiple sclerosis	0.000384	0.00196	CcSEcCtD
Trimipramine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000384	0.00196	CcSEcCtD
Trimipramine—Hypertension—Prednisolone—multiple sclerosis	0.000383	0.00195	CcSEcCtD
Trimipramine—Eosinophilia—Methotrexate—multiple sclerosis	0.000383	0.00195	CcSEcCtD
Trimipramine—Fatigue—Mitoxantrone—multiple sclerosis	0.00038	0.00194	CcSEcCtD
Trimipramine—Arrhythmia—Dexamethasone—multiple sclerosis	0.00038	0.00194	CcSEcCtD
Trimipramine—Arrhythmia—Betamethasone—multiple sclerosis	0.00038	0.00194	CcSEcCtD
Trimipramine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000379	0.00193	CcSEcCtD
Trimipramine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000378	0.00193	CcSEcCtD
Trimipramine—Constipation—Mitoxantrone—multiple sclerosis	0.000377	0.00193	CcSEcCtD
Trimipramine—Alopecia—Betamethasone—multiple sclerosis	0.000376	0.00192	CcSEcCtD
Trimipramine—Alopecia—Dexamethasone—multiple sclerosis	0.000376	0.00192	CcSEcCtD
Trimipramine—Diarrhoea—Azathioprine—multiple sclerosis	0.000373	0.00191	CcSEcCtD
Trimipramine—Discomfort—Prednisolone—multiple sclerosis	0.000373	0.0019	CcSEcCtD
Trimipramine—Hallucination—Prednisone—multiple sclerosis	0.000368	0.00188	CcSEcCtD
Trimipramine—Malaise—Triamcinolone—multiple sclerosis	0.000368	0.00188	CcSEcCtD
Trimipramine—Pancytopenia—Methotrexate—multiple sclerosis	0.000367	0.00187	CcSEcCtD
Trimipramine—Malaise—Methylprednisolone—multiple sclerosis	0.000367	0.00187	CcSEcCtD
Trimipramine—HTR2A—nervous system—multiple sclerosis	0.000366	0.00183	CbGeAlD
Trimipramine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000364	0.00186	CcSEcCtD
Trimipramine—Oedema—Prednisolone—multiple sclerosis	0.000362	0.00185	CcSEcCtD
Trimipramine—Dizziness—Azathioprine—multiple sclerosis	0.000361	0.00184	CcSEcCtD
Trimipramine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000356	0.00182	CcSEcCtD
Trimipramine—Convulsion—Triamcinolone—multiple sclerosis	0.000353	0.0018	CcSEcCtD
Trimipramine—Tachycardia—Prednisolone—multiple sclerosis	0.000353	0.0018	CcSEcCtD
Trimipramine—Convulsion—Methylprednisolone—multiple sclerosis	0.000353	0.0018	CcSEcCtD
Trimipramine—HTR2A—central nervous system—multiple sclerosis	0.000352	0.00176	CbGeAlD
Trimipramine—Hypertension—Triamcinolone—multiple sclerosis	0.000352	0.0018	CcSEcCtD
Trimipramine—Hypertension—Methylprednisolone—multiple sclerosis	0.000351	0.00179	CcSEcCtD
Trimipramine—Urticaria—Mitoxantrone—multiple sclerosis	0.000351	0.00179	CcSEcCtD
Trimipramine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000349	0.00178	CcSEcCtD
Trimipramine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000349	0.00178	CcSEcCtD
Trimipramine—Vomiting—Azathioprine—multiple sclerosis	0.000347	0.00177	CcSEcCtD
Trimipramine—Anxiety—Methylprednisolone—multiple sclerosis	0.000345	0.00176	CcSEcCtD
Trimipramine—Drowsiness—Methotrexate—multiple sclerosis	0.000345	0.00176	CcSEcCtD
Trimipramine—HTR2A—cerebellum—multiple sclerosis	0.000344	0.00172	CbGeAlD
Trimipramine—Rash—Azathioprine—multiple sclerosis	0.000344	0.00176	CcSEcCtD
Trimipramine—Dermatitis—Azathioprine—multiple sclerosis	0.000344	0.00176	CcSEcCtD
Trimipramine—Flushing—Prednisone—multiple sclerosis	0.000344	0.00175	CcSEcCtD
Trimipramine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000343	0.00175	CcSEcCtD
Trimipramine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000343	0.00175	CcSEcCtD
Trimipramine—Discomfort—Triamcinolone—multiple sclerosis	0.000343	0.00175	CcSEcCtD
Trimipramine—Discomfort—Methylprednisolone—multiple sclerosis	0.000342	0.00175	CcSEcCtD
Trimipramine—Headache—Azathioprine—multiple sclerosis	0.000342	0.00175	CcSEcCtD
Trimipramine—Dry mouth—Triamcinolone—multiple sclerosis	0.00034	0.00173	CcSEcCtD
Trimipramine—CYP3A4—nervous system—multiple sclerosis	0.000339	0.00169	CbGeAlD
Trimipramine—Stomatitis—Methotrexate—multiple sclerosis	0.000336	0.00172	CcSEcCtD
Trimipramine—Confusional state—Methylprednisolone—multiple sclerosis	0.000335	0.00171	CcSEcCtD
Trimipramine—HRH1—brain—multiple sclerosis	0.000335	0.00167	CbGeAlD
Trimipramine—Malaise—Dexamethasone—multiple sclerosis	0.000334	0.0017	CcSEcCtD
Trimipramine—Malaise—Betamethasone—multiple sclerosis	0.000334	0.0017	CcSEcCtD
Trimipramine—CYP2D6—nervous system—multiple sclerosis	0.000333	0.00166	CbGeAlD
Trimipramine—Oedema—Triamcinolone—multiple sclerosis	0.000333	0.0017	CcSEcCtD
Trimipramine—Arrhythmia—Prednisone—multiple sclerosis	0.000331	0.00169	CcSEcCtD
Trimipramine—ADRA2A—brain—multiple sclerosis	0.000329	0.00164	CbGeAlD
Trimipramine—Insomnia—Prednisolone—multiple sclerosis	0.000327	0.00167	CcSEcCtD
Trimipramine—Alopecia—Prednisone—multiple sclerosis	0.000327	0.00167	CcSEcCtD
Trimipramine—CYP3A4—central nervous system—multiple sclerosis	0.000326	0.00163	CbGeAlD
Trimipramine—Paraesthesia—Prednisolone—multiple sclerosis	0.000325	0.00166	CcSEcCtD
Trimipramine—Tachycardia—Triamcinolone—multiple sclerosis	0.000325	0.00166	CcSEcCtD
Trimipramine—Nausea—Azathioprine—multiple sclerosis	0.000324	0.00166	CcSEcCtD
Trimipramine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000324	0.00165	CcSEcCtD
Trimipramine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000322	0.00164	CcSEcCtD
Trimipramine—CYP2D6—central nervous system—multiple sclerosis	0.000321	0.0016	CbGeAlD
Trimipramine—Convulsion—Betamethasone—multiple sclerosis	0.000321	0.00164	CcSEcCtD
Trimipramine—Convulsion—Dexamethasone—multiple sclerosis	0.000321	0.00164	CcSEcCtD
Trimipramine—Hypertension—Betamethasone—multiple sclerosis	0.00032	0.00163	CcSEcCtD
Trimipramine—Hypertension—Dexamethasone—multiple sclerosis	0.00032	0.00163	CcSEcCtD
Trimipramine—ABCB1—medulla oblongata—multiple sclerosis	0.000319	0.00159	CbGeAlD
Trimipramine—Asthenia—Mitoxantrone—multiple sclerosis	0.000317	0.00162	CcSEcCtD
Trimipramine—Anxiety—Dexamethasone—multiple sclerosis	0.000314	0.0016	CcSEcCtD
Trimipramine—Anxiety—Betamethasone—multiple sclerosis	0.000314	0.0016	CcSEcCtD
Trimipramine—CYP2D6—cerebellum—multiple sclerosis	0.000314	0.00157	CbGeAlD
Trimipramine—Discomfort—Dexamethasone—multiple sclerosis	0.000311	0.00159	CcSEcCtD
Trimipramine—Discomfort—Betamethasone—multiple sclerosis	0.000311	0.00159	CcSEcCtD
Trimipramine—Hypotension—Methylprednisolone—multiple sclerosis	0.00031	0.00158	CcSEcCtD
Trimipramine—Vision blurred—Prednisone—multiple sclerosis	0.000304	0.00155	CcSEcCtD
Trimipramine—Oedema—Betamethasone—multiple sclerosis	0.000302	0.00154	CcSEcCtD
Trimipramine—Oedema—Dexamethasone—multiple sclerosis	0.000302	0.00154	CcSEcCtD
Trimipramine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000302	0.00154	CcSEcCtD
Trimipramine—Insomnia—Triamcinolone—multiple sclerosis	0.000301	0.00154	CcSEcCtD
Trimipramine—Insomnia—Methylprednisolone—multiple sclerosis	0.0003	0.00153	CcSEcCtD
Trimipramine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000299	0.00153	CcSEcCtD
Trimipramine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000299	0.00153	CcSEcCtD
Trimipramine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000298	0.00152	CcSEcCtD
Trimipramine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000298	0.00152	CcSEcCtD
Trimipramine—Agitation—Prednisone—multiple sclerosis	0.000296	0.00151	CcSEcCtD
Trimipramine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000296	0.00151	CcSEcCtD
Trimipramine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000296	0.00151	CcSEcCtD
Trimipramine—Tachycardia—Betamethasone—multiple sclerosis	0.000295	0.0015	CcSEcCtD
Trimipramine—Tachycardia—Dexamethasone—multiple sclerosis	0.000295	0.0015	CcSEcCtD
Trimipramine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000293	0.0015	CcSEcCtD
Trimipramine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000292	0.00149	CcSEcCtD
Trimipramine—ABCB1—midbrain—multiple sclerosis	0.000292	0.00146	CbGeAlD
Trimipramine—Malaise—Prednisone—multiple sclerosis	0.000291	0.00148	CcSEcCtD
Trimipramine—Tinnitus—Methotrexate—multiple sclerosis	0.000289	0.00147	CcSEcCtD
Trimipramine—Anorexia—Dexamethasone—multiple sclerosis	0.000288	0.00147	CcSEcCtD
Trimipramine—Anorexia—Betamethasone—multiple sclerosis	0.000288	0.00147	CcSEcCtD
Trimipramine—Urticaria—Prednisolone—multiple sclerosis	0.000288	0.00147	CcSEcCtD
Trimipramine—Fatigue—Triamcinolone—multiple sclerosis	0.000287	0.00147	CcSEcCtD
Trimipramine—Fatigue—Methylprednisolone—multiple sclerosis	0.000286	0.00146	CcSEcCtD
Trimipramine—ABCB1—spinal cord—multiple sclerosis	0.000285	0.00142	CbGeAlD
Trimipramine—Hypotension—Betamethasone—multiple sclerosis	0.000282	0.00144	CcSEcCtD
Trimipramine—Hypotension—Dexamethasone—multiple sclerosis	0.000282	0.00144	CcSEcCtD
Trimipramine—Vomiting—Mitoxantrone—multiple sclerosis	0.000281	0.00143	CcSEcCtD
Trimipramine—HTR2A—brain—multiple sclerosis	0.00028	0.0014	CbGeAlD
Trimipramine—Convulsion—Prednisone—multiple sclerosis	0.000279	0.00143	CcSEcCtD
Trimipramine—Hypertension—Prednisone—multiple sclerosis	0.000278	0.00142	CcSEcCtD
Trimipramine—Rash—Mitoxantrone—multiple sclerosis	0.000278	0.00142	CcSEcCtD
Trimipramine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000278	0.00142	CcSEcCtD
Trimipramine—Headache—Mitoxantrone—multiple sclerosis	0.000276	0.00141	CcSEcCtD
Trimipramine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000274	0.0014	CcSEcCtD
Trimipramine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000274	0.0014	CcSEcCtD
Trimipramine—Anxiety—Prednisone—multiple sclerosis	0.000273	0.0014	CcSEcCtD
Trimipramine—Alopecia—Methotrexate—multiple sclerosis	0.000273	0.0014	CcSEcCtD
Trimipramine—Insomnia—Betamethasone—multiple sclerosis	0.000273	0.00139	CcSEcCtD
Trimipramine—Insomnia—Dexamethasone—multiple sclerosis	0.000273	0.00139	CcSEcCtD
Trimipramine—Oxcarbazepine—ALB—multiple sclerosis	0.000272	0.0759	CrCbGaD
Trimipramine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000271	0.00138	CcSEcCtD
Trimipramine—Paraesthesia—Betamethasone—multiple sclerosis	0.000271	0.00138	CcSEcCtD
Trimipramine—Discomfort—Prednisone—multiple sclerosis	0.000271	0.00138	CcSEcCtD
Trimipramine—Dyspepsia—Betamethasone—multiple sclerosis	0.000266	0.00136	CcSEcCtD
Trimipramine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000266	0.00136	CcSEcCtD
Trimipramine—Urticaria—Triamcinolone—multiple sclerosis	0.000264	0.00135	CcSEcCtD
Trimipramine—Urticaria—Methylprednisolone—multiple sclerosis	0.000264	0.00135	CcSEcCtD
Trimipramine—Dysgeusia—Methotrexate—multiple sclerosis	0.000264	0.00135	CcSEcCtD
Trimipramine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000263	0.00134	CcSEcCtD
Trimipramine—Oedema—Prednisone—multiple sclerosis	0.000263	0.00134	CcSEcCtD
Trimipramine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000263	0.00134	CcSEcCtD
Trimipramine—Decreased appetite—Betamethasone—multiple sclerosis	0.000263	0.00134	CcSEcCtD
Trimipramine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000263	0.00134	CcSEcCtD
Trimipramine—Nausea—Mitoxantrone—multiple sclerosis	0.000262	0.00134	CcSEcCtD
Trimipramine—Chlorpromazine—BCHE—multiple sclerosis	0.000261	0.0728	CrCbGaD
Trimipramine—Fatigue—Betamethasone—multiple sclerosis	0.00026	0.00133	CcSEcCtD
Trimipramine—Fatigue—Dexamethasone—multiple sclerosis	0.00026	0.00133	CcSEcCtD
Trimipramine—Tachycardia—Prednisone—multiple sclerosis	0.000257	0.00131	CcSEcCtD
Trimipramine—CYP2D6—brain—multiple sclerosis	0.000255	0.00127	CbGeAlD
Trimipramine—Vision blurred—Methotrexate—multiple sclerosis	0.000254	0.0013	CcSEcCtD
Trimipramine—Anorexia—Prednisone—multiple sclerosis	0.000251	0.00128	CcSEcCtD
Trimipramine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00025	0.00128	CcSEcCtD
Trimipramine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000249	0.00127	CcSEcCtD
Trimipramine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000249	0.00127	CcSEcCtD
Trimipramine—Malaise—Methotrexate—multiple sclerosis	0.000243	0.00124	CcSEcCtD
Trimipramine—Urticaria—Dexamethasone—multiple sclerosis	0.00024	0.00122	CcSEcCtD
Trimipramine—Urticaria—Betamethasone—multiple sclerosis	0.00024	0.00122	CcSEcCtD
Trimipramine—ABCB1—nervous system—multiple sclerosis	0.00024	0.0012	CbGeAlD
Trimipramine—Dizziness—Prednisolone—multiple sclerosis	0.000239	0.00122	CcSEcCtD
Trimipramine—Asthenia—Triamcinolone—multiple sclerosis	0.000239	0.00122	CcSEcCtD
Trimipramine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000239	0.00122	CcSEcCtD
Trimipramine—Abdominal pain—Betamethasone—multiple sclerosis	0.000239	0.00122	CcSEcCtD
Trimipramine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000239	0.00122	CcSEcCtD
Trimipramine—Body temperature increased—Betamethasone—multiple sclerosis	0.000239	0.00122	CcSEcCtD
Trimipramine—Asthenia—Methylprednisolone—multiple sclerosis	0.000238	0.00122	CcSEcCtD
Trimipramine—Insomnia—Prednisone—multiple sclerosis	0.000238	0.00121	CcSEcCtD
Trimipramine—Paraesthesia—Prednisone—multiple sclerosis	0.000236	0.00121	CcSEcCtD
Trimipramine—Pruritus—Triamcinolone—multiple sclerosis	0.000236	0.0012	CcSEcCtD
Trimipramine—Pruritus—Methylprednisolone—multiple sclerosis	0.000235	0.0012	CcSEcCtD
Trimipramine—Convulsion—Methotrexate—multiple sclerosis	0.000233	0.00119	CcSEcCtD
Trimipramine—Dyspepsia—Prednisone—multiple sclerosis	0.000232	0.00118	CcSEcCtD
Trimipramine—ABCB1—central nervous system—multiple sclerosis	0.000231	0.00115	CbGeAlD
Trimipramine—Decreased appetite—Prednisone—multiple sclerosis	0.000229	0.00117	CcSEcCtD
Trimipramine—Rash—Prednisolone—multiple sclerosis	0.000228	0.00117	CcSEcCtD
Trimipramine—Dermatitis—Prednisolone—multiple sclerosis	0.000228	0.00116	CcSEcCtD
Trimipramine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000227	0.00116	CcSEcCtD
Trimipramine—Fatigue—Prednisone—multiple sclerosis	0.000227	0.00116	CcSEcCtD
Trimipramine—Headache—Prednisolone—multiple sclerosis	0.000227	0.00116	CcSEcCtD
Trimipramine—Discomfort—Methotrexate—multiple sclerosis	0.000227	0.00116	CcSEcCtD
Trimipramine—ABCB1—cerebellum—multiple sclerosis	0.000226	0.00113	CbGeAlD
Trimipramine—Constipation—Prednisone—multiple sclerosis	0.000225	0.00115	CcSEcCtD
Trimipramine—Confusional state—Methotrexate—multiple sclerosis	0.000222	0.00113	CcSEcCtD
Trimipramine—Dizziness—Triamcinolone—multiple sclerosis	0.00022	0.00112	CcSEcCtD
Trimipramine—Dizziness—Methylprednisolone—multiple sclerosis	0.00022	0.00112	CcSEcCtD
Trimipramine—Feeling abnormal—Prednisone—multiple sclerosis	0.000217	0.00111	CcSEcCtD
Trimipramine—Asthenia—Betamethasone—multiple sclerosis	0.000217	0.00111	CcSEcCtD
Trimipramine—Asthenia—Dexamethasone—multiple sclerosis	0.000217	0.00111	CcSEcCtD
Trimipramine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000215	0.0011	CcSEcCtD
Trimipramine—Nausea—Prednisolone—multiple sclerosis	0.000215	0.0011	CcSEcCtD
Trimipramine—Pruritus—Dexamethasone—multiple sclerosis	0.000214	0.00109	CcSEcCtD
Trimipramine—Pruritus—Betamethasone—multiple sclerosis	0.000214	0.00109	CcSEcCtD
Trimipramine—Vomiting—Triamcinolone—multiple sclerosis	0.000212	0.00108	CcSEcCtD
Trimipramine—Vomiting—Methylprednisolone—multiple sclerosis	0.000211	0.00108	CcSEcCtD
Trimipramine—Rash—Triamcinolone—multiple sclerosis	0.00021	0.00107	CcSEcCtD
Trimipramine—Dermatitis—Triamcinolone—multiple sclerosis	0.00021	0.00107	CcSEcCtD
Trimipramine—Anorexia—Methotrexate—multiple sclerosis	0.00021	0.00107	CcSEcCtD
Trimipramine—Rash—Methylprednisolone—multiple sclerosis	0.000209	0.00107	CcSEcCtD
Trimipramine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000209	0.00107	CcSEcCtD
Trimipramine—Urticaria—Prednisone—multiple sclerosis	0.000209	0.00107	CcSEcCtD
Trimipramine—Headache—Triamcinolone—multiple sclerosis	0.000209	0.00106	CcSEcCtD
Trimipramine—Headache—Methylprednisolone—multiple sclerosis	0.000208	0.00106	CcSEcCtD
Trimipramine—Body temperature increased—Prednisone—multiple sclerosis	0.000208	0.00106	CcSEcCtD
Trimipramine—Abdominal pain—Prednisone—multiple sclerosis	0.000208	0.00106	CcSEcCtD
Trimipramine—Diarrhoea—Betamethasone—multiple sclerosis	0.000207	0.00106	CcSEcCtD
Trimipramine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000207	0.00106	CcSEcCtD
Trimipramine—Acepromazine—ALB—multiple sclerosis	0.000206	0.0573	CrCbGaD
Trimipramine—Hypotension—Methotrexate—multiple sclerosis	0.000205	0.00105	CcSEcCtD
Trimipramine—Dizziness—Betamethasone—multiple sclerosis	0.0002	0.00102	CcSEcCtD
Trimipramine—Dizziness—Dexamethasone—multiple sclerosis	0.0002	0.00102	CcSEcCtD
Trimipramine—Insomnia—Methotrexate—multiple sclerosis	0.000199	0.00102	CcSEcCtD
Trimipramine—Nausea—Triamcinolone—multiple sclerosis	0.000198	0.00101	CcSEcCtD
Trimipramine—Paraesthesia—Methotrexate—multiple sclerosis	0.000197	0.00101	CcSEcCtD
Trimipramine—Nausea—Methylprednisolone—multiple sclerosis	0.000197	0.00101	CcSEcCtD
Trimipramine—Somnolence—Methotrexate—multiple sclerosis	0.000195	0.000998	CcSEcCtD
Trimipramine—Dyspepsia—Methotrexate—multiple sclerosis	0.000194	0.000988	CcSEcCtD
Trimipramine—Vomiting—Betamethasone—multiple sclerosis	0.000192	0.00098	CcSEcCtD
Trimipramine—Vomiting—Dexamethasone—multiple sclerosis	0.000192	0.00098	CcSEcCtD
Trimipramine—Decreased appetite—Methotrexate—multiple sclerosis	0.000191	0.000976	CcSEcCtD
Trimipramine—Rash—Betamethasone—multiple sclerosis	0.00019	0.000972	CcSEcCtD
Trimipramine—Rash—Dexamethasone—multiple sclerosis	0.00019	0.000972	CcSEcCtD
Trimipramine—Dermatitis—Betamethasone—multiple sclerosis	0.00019	0.000971	CcSEcCtD
Trimipramine—Dermatitis—Dexamethasone—multiple sclerosis	0.00019	0.000971	CcSEcCtD
Trimipramine—Fatigue—Methotrexate—multiple sclerosis	0.00019	0.000968	CcSEcCtD
Trimipramine—Headache—Dexamethasone—multiple sclerosis	0.000189	0.000966	CcSEcCtD
Trimipramine—Headache—Betamethasone—multiple sclerosis	0.000189	0.000966	CcSEcCtD
Trimipramine—Asthenia—Prednisone—multiple sclerosis	0.000189	0.000963	CcSEcCtD
Trimipramine—Pruritus—Prednisone—multiple sclerosis	0.000186	0.00095	CcSEcCtD
Trimipramine—ABCB1—brain—multiple sclerosis	0.000183	0.000915	CbGeAlD
Trimipramine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000181	0.000925	CcSEcCtD
Trimipramine—Diarrhoea—Prednisone—multiple sclerosis	0.00018	0.000919	CcSEcCtD
Trimipramine—Nausea—Betamethasone—multiple sclerosis	0.000179	0.000916	CcSEcCtD
Trimipramine—Nausea—Dexamethasone—multiple sclerosis	0.000179	0.000916	CcSEcCtD
Trimipramine—Urticaria—Methotrexate—multiple sclerosis	0.000175	0.000892	CcSEcCtD
Trimipramine—Dizziness—Prednisone—multiple sclerosis	0.000174	0.000888	CcSEcCtD
Trimipramine—Abdominal pain—Methotrexate—multiple sclerosis	0.000174	0.000887	CcSEcCtD
Trimipramine—Body temperature increased—Methotrexate—multiple sclerosis	0.000174	0.000887	CcSEcCtD
Trimipramine—Vomiting—Prednisone—multiple sclerosis	0.000167	0.000854	CcSEcCtD
Trimipramine—Rash—Prednisone—multiple sclerosis	0.000166	0.000847	CcSEcCtD
Trimipramine—Dermatitis—Prednisone—multiple sclerosis	0.000166	0.000846	CcSEcCtD
Trimipramine—Headache—Prednisone—multiple sclerosis	0.000165	0.000841	CcSEcCtD
Trimipramine—Asthenia—Methotrexate—multiple sclerosis	0.000158	0.000805	CcSEcCtD
Trimipramine—Clomipramine—ALB—multiple sclerosis	0.000157	0.0436	CrCbGaD
Trimipramine—Nausea—Prednisone—multiple sclerosis	0.000156	0.000798	CcSEcCtD
Trimipramine—Pruritus—Methotrexate—multiple sclerosis	0.000156	0.000794	CcSEcCtD
Trimipramine—Nortriptyline—ALB—multiple sclerosis	0.000153	0.0426	CrCbGaD
Trimipramine—Diarrhoea—Methotrexate—multiple sclerosis	0.00015	0.000768	CcSEcCtD
Trimipramine—Dizziness—Methotrexate—multiple sclerosis	0.000145	0.000742	CcSEcCtD
Trimipramine—Vomiting—Methotrexate—multiple sclerosis	0.00014	0.000714	CcSEcCtD
Trimipramine—Rash—Methotrexate—multiple sclerosis	0.000139	0.000708	CcSEcCtD
Trimipramine—Dermatitis—Methotrexate—multiple sclerosis	0.000139	0.000707	CcSEcCtD
Trimipramine—Headache—Methotrexate—multiple sclerosis	0.000138	0.000703	CcSEcCtD
Trimipramine—Nausea—Methotrexate—multiple sclerosis	0.000131	0.000667	CcSEcCtD
Trimipramine—Chlorpromazine—ALB—multiple sclerosis	0.000107	0.0299	CrCbGaD
Trimipramine—Amitriptyline—ALB—multiple sclerosis	0.000106	0.0296	CrCbGaD
Trimipramine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	1.66e-05	0.000141	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	1.65e-05	0.000141	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	1.64e-05	0.00014	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CD86—multiple sclerosis	1.64e-05	0.00014	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	1.64e-05	0.00014	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CD86—multiple sclerosis	1.63e-05	0.000139	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	1.63e-05	0.000139	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	1.63e-05	0.000139	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	1.62e-05	0.000139	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	1.62e-05	0.000138	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	1.62e-05	0.000138	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	1.62e-05	0.000138	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	1.62e-05	0.000138	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	1.61e-05	0.000138	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	1.6e-05	0.000137	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CD80—multiple sclerosis	1.6e-05	0.000137	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	1.59e-05	0.000136	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	1.58e-05	0.000135	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	1.56e-05	0.000134	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	1.56e-05	0.000133	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	1.56e-05	0.000133	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.55e-05	0.000132	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.55e-05	0.000132	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	1.55e-05	0.000132	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	1.54e-05	0.000131	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.53e-05	0.000131	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—POMC—multiple sclerosis	1.52e-05	0.00013	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	1.52e-05	0.00013	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	1.51e-05	0.000129	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	1.51e-05	0.000128	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	1.5e-05	0.000128	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	1.49e-05	0.000128	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	1.49e-05	0.000127	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CCL2—multiple sclerosis	1.49e-05	0.000127	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	1.49e-05	0.000127	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	1.49e-05	0.000127	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	1.48e-05	0.000127	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	1.48e-05	0.000126	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	1.48e-05	0.000126	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	1.47e-05	0.000126	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	1.47e-05	0.000126	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	1.47e-05	0.000126	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.46e-05	0.000125	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	1.46e-05	0.000124	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	1.45e-05	0.000124	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	1.45e-05	0.000123	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	1.44e-05	0.000123	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CD86—multiple sclerosis	1.44e-05	0.000123	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.44e-05	0.000123	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	1.43e-05	0.000122	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.43e-05	0.000122	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	1.42e-05	0.000122	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	1.42e-05	0.000121	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	1.42e-05	0.000121	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	1.42e-05	0.000121	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CD86—multiple sclerosis	1.42e-05	0.000121	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	1.41e-05	0.000121	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CD86—multiple sclerosis	1.41e-05	0.000121	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.41e-05	0.000121	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	1.39e-05	0.000119	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	1.39e-05	0.000119	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	1.39e-05	0.000118	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	1.38e-05	0.000118	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	1.37e-05	0.000117	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	1.37e-05	0.000117	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	1.36e-05	0.000116	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	1.36e-05	0.000116	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	1.35e-05	0.000116	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	1.35e-05	0.000115	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	1.35e-05	0.000115	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	1.35e-05	0.000115	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.35e-05	0.000115	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.34e-05	0.000115	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.33e-05	0.000114	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.32e-05	0.000113	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—APOE—multiple sclerosis	1.32e-05	0.000113	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.32e-05	0.000112	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	1.31e-05	0.000112	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	1.29e-05	0.00011	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.29e-05	0.00011	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.29e-05	0.00011	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	1.28e-05	0.000109	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.27e-05	0.000108	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.26e-05	0.000108	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	1.26e-05	0.000107	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	1.26e-05	0.000107	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	1.26e-05	0.000107	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.25e-05	0.000107	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.25e-05	0.000107	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—APOE—multiple sclerosis	1.24e-05	0.000106	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	1.24e-05	0.000106	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.24e-05	0.000106	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.23e-05	0.000105	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.23e-05	0.000105	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.23e-05	0.000105	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.23e-05	0.000105	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.23e-05	0.000105	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.21e-05	0.000103	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.2e-05	0.000103	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.2e-05	0.000102	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.19e-05	0.000102	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	1.18e-05	0.0001	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.17e-05	0.0001	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.16e-05	9.91e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	1.15e-05	9.83e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.14e-05	9.75e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.14e-05	9.75e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.14e-05	9.73e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	1.14e-05	9.72e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	1.14e-05	9.69e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.13e-05	9.64e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.13e-05	9.61e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL2—multiple sclerosis	1.13e-05	9.61e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.13e-05	9.61e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	1.12e-05	9.56e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.12e-05	9.55e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.12e-05	9.54e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	1.11e-05	9.49e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.11e-05	9.44e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.09e-05	9.28e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.08e-05	9.23e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	1.08e-05	9.23e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—POMC—multiple sclerosis	1.07e-05	9.11e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	1.07e-05	9.09e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	1.06e-05	9.03e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.05e-05	8.96e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	1.05e-05	8.92e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.04e-05	8.87e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	1.04e-05	8.84e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.03e-05	8.81e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.03e-05	8.8e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.01e-05	8.63e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	1.01e-05	8.61e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1e-05	8.57e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—POMC—multiple sclerosis	9.97e-06	8.51e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	9.81e-06	8.38e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—POMC—multiple sclerosis	9.79e-06	8.36e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	9.76e-06	8.33e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—ALB—multiple sclerosis	9.73e-06	8.31e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	9.61e-06	8.2e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	9.61e-06	8.2e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	9.6e-06	8.19e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	9.58e-06	8.18e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	9.54e-06	8.15e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	9.47e-06	8.09e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	9.4e-06	8.02e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	9.39e-06	8.02e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	9.39e-06	8.02e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	9.37e-06	8e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	9.2e-06	7.85e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	8.92e-06	7.62e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	8.86e-06	7.56e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—APOE—multiple sclerosis	8.8e-06	7.52e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MYC—multiple sclerosis	8.8e-06	7.51e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.8e-06	7.51e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	8.78e-06	7.49e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	8.73e-06	7.46e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	8.72e-06	7.44e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	8.7e-06	7.43e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	8.7e-06	7.42e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	8.65e-06	7.39e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	8.61e-06	7.35e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—APOE—multiple sclerosis	8.59e-06	7.34e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	8.54e-06	7.29e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	8.53e-06	7.29e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	8.39e-06	7.17e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	8.35e-06	7.13e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	8.35e-06	7.13e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	8.31e-06	7.09e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	8.23e-06	7.03e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—APOE—multiple sclerosis	8.1e-06	6.91e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—APOE—multiple sclerosis	8.03e-06	6.85e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	7.99e-06	6.83e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	7.95e-06	6.79e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	7.95e-06	6.78e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	7.93e-06	6.77e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	7.9e-06	6.75e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	7.57e-06	6.46e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—POMC—multiple sclerosis	7.56e-06	6.46e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—POMC—multiple sclerosis	7.38e-06	6.3e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL2—multiple sclerosis	7.37e-06	6.29e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	7.33e-06	6.26e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	7.32e-06	6.25e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	7.25e-06	6.19e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL2—multiple sclerosis	7.24e-06	6.18e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	7.22e-06	6.16e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	7.2e-06	6.15e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	7.1e-06	6.06e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	7.07e-06	6.03e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	7.06e-06	6.03e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	7.03e-06	6e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	6.98e-06	5.96e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—POMC—multiple sclerosis	6.96e-06	5.94e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—POMC—multiple sclerosis	6.9e-06	5.89e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ALB—multiple sclerosis	6.89e-06	5.89e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	6.86e-06	5.86e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	6.85e-06	5.85e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	6.8e-06	5.81e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	6.78e-06	5.79e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ALB—multiple sclerosis	6.73e-06	5.74e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	6.73e-06	5.74e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	6.72e-06	5.74e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	6.65e-06	5.68e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—multiple sclerosis	6.62e-06	5.65e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	6.6e-06	5.63e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	6.57e-06	5.6e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	6.56e-06	5.6e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	6.55e-06	5.59e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	6.53e-06	5.58e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	6.51e-06	5.56e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	6.42e-06	5.48e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	6.39e-06	5.45e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ALB—multiple sclerosis	6.34e-06	5.41e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ALB—multiple sclerosis	6.29e-06	5.37e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	6.25e-06	5.34e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	6.24e-06	5.33e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	6.24e-06	5.32e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	6.2e-06	5.3e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	6.12e-06	5.22e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	6.1e-06	5.21e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	6.09e-06	5.2e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	5.98e-06	5.1e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MYC—multiple sclerosis	5.76e-06	4.92e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	5.75e-06	4.91e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	5.67e-06	4.84e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MYC—multiple sclerosis	5.66e-06	4.83e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	5.66e-06	4.83e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	5.64e-06	4.82e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	5.64e-06	4.81e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	5.55e-06	4.74e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	5.55e-06	4.74e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	5.55e-06	4.74e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	5.54e-06	4.73e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	5.54e-06	4.73e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	5.43e-06	4.64e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—APOE—multiple sclerosis	5.29e-06	4.52e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	5.16e-06	4.4e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	5.15e-06	4.39e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	5.11e-06	4.36e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	5.05e-06	4.31e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	4.93e-06	4.21e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	4.91e-06	4.19e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	4.7e-06	4.01e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—POMC—multiple sclerosis	4.55e-06	3.88e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—multiple sclerosis	4.33e-06	3.7e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	4.26e-06	3.64e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—multiple sclerosis	4.25e-06	3.63e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	4.17e-06	3.56e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ALB—multiple sclerosis	4.15e-06	3.54e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	3.88e-06	3.31e-05	CbGpPWpGaD
